Accelerating
Ophthalmic
Innovation
Strategic advisory, innovation sourcing, and operational support for ophthalmic companies, investors, and industry partners; spun out of a decade of specialized venture investing.
Service Platform
Delivering comprehensive ophthalmic expertise across the full innovation lifecycle from early-stage strategy through commercialization and business development.
-
Competitor analysis, opportunity identification, and technology evaluation, drawing on a decade of identifying and evaluating over 1,000 ophthalmic opportunities. We provide market intelligence, landscape mapping, and technology scouting; targeted due diligence and comparative analysis; opportunity identification and access to the founder ecosystem; and curated board-ready KOLs and clinicians.
-
Connecting innovators and industry partners and navigating the life science landscape. We support marketability assessment, portfolio restructuring, and valuation analysis; market access, corporate development, and strategic partnerships; and deal negotiation and transaction support — applying the discipline of a specialist venture firm to the strategic challenges life science companies, investors, and partners face every day.
-
Hands-on expertise delivering critical clinical, regulatory, governance, and management support across the company lifecycle. For early-stage companies and founders, this includes clinical and regulatory strategy, foundational corporate governance and operational build-outs, and critical hire sourcing and stand-in executive coverage.
Market Intelligence
//
Landscape Mapping
//
Targeted Due Dilligence
//
Comparative Analysis
//
Technology Scouting
//
Opportunity Identification
//
Marketability Assessment
//
Portfolio Restructuring
//
Valuation Analysis
//
Corporate Development
//
Strategic Partnerships
//
Deal Negotiation
//
Transaction Support
//
Clinical & Regulatory Strategy
//
Operational Buildouts
//
Critical Hire Sourcing
//
Stand-in Executive Coverage
//
Market Intelligence // Landscape Mapping // Targeted Due Dilligence // Comparative Analysis // Technology Scouting // Opportunity Identification // Marketability Assessment // Portfolio Restructuring // Valuation Analysis // Corporate Development // Strategic Partnerships // Deal Negotiation // Transaction Support // Clinical & Regulatory Strategy // Operational Buildouts // Critical Hire Sourcing // Stand-in Executive Coverage //
Proven Across the Innovation Lifecycle
Companies Built
15 ophthalmic companies funded since 2014, with hands-on involvement from pre-formation through commercialization. Engagements have included a $9M SPV, Series A co-leads, board seats from inception, and clinical mapping for a robotic cataract surgery milestone.
15 companies funded · 1,000+ technologies evaluated
Capital Mobilized
$27M deployed across the portfolio, informed by deep clinical, technical, and market diligence. ExSight-backed companies have continued to attract institutional capital well beyond initial investment — including relationships built with Lilly, RA Capital, JJDC, Novartis Venture Fund, Bios Partners, and Boehringer Ingelheim.
$27M deployed · $750M+ in follow-on capital raised
Outcomes Delivered
Four successful exits and two business development deals demonstrate value creation across the innovation lifecycle. Engagements have culminated in a $1B+ Re-Vana partnership workstream and exits including Bausch + Lomb's acquisition of Elios Vision and Novartis's acquisition of DTx Pharma.
$1B+ partnership workstream